Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. KEGG DRUG DrugBank 薬物名（臨床試験情報から抽出） KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Abiraterone acetate 💬1件: Abiraterone1件: Abiraterone acetate1件: CYP17A 💬 5件: Cortisol synthesis and secretion, Cushing syndrome, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬2件: 75, 81 💬
2 Corticotropin 💬1件: Corticotropin3件: Acth; Adrenocorticotropic hormone; Corticotropin1件: MC2R 💬 6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬6件: 13, 78, 81, 84, 145, 222 💬
3 Corticotropin, repository 💬1件: Corticotropin3件: Acth; Adrenocorticotropic hormone; Corticotropin1件: MC2R 💬 6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬6件: 13, 78, 81, 84, 145, 222 💬
4 Cortisone 💬1件: Cortisone0件: 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬-
5 Cortisone acetate 💬1件: Cortisone acetate1件: Cortisone acetate1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
6 Crinecerfont 💬1件: Crinecerfont1件: Crinecerfont1件: CRHR1 💬 5件: Cushing syndrome, Hormone signaling, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 81 💬
7 Dexamethasone 💬1件: Dexamethasone2件: Dexamethasone; Dexamethasone sodium phosphate1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬23件: 13, 14, 16, 19, 28, 35, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 222, 235, 257, 296, 299, 331 💬
8 Dexamethasone phosphate 💬1件: Dexamethasone2件: Dexamethasone; Dexamethasone sodium phosphate1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬23件: 13, 14, 16, 19, 28, 35, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 222, 235, 257, 296, 299, 331 💬
9 Dexamethasone sodium phosphate 💬1件: Dexamethasone2件: Dexamethasone; Dexamethasone sodium phosphate1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬23件: 13, 14, 16, 19, 28, 35, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 222, 235, 257, 296, 299, 331 💬
10 Fludrocortisone 💬1件: Fludrocortisone1件: Fludrocortisone1件: NR3C2 💬 1件: Aldosterone-regulated sodium reabsorption 💬3件: 6, 17, 81 💬
11 Fludrocortisone acetate 💬1件: Fludrocortisone1件: Fludrocortisone1件: NR3C2 💬 1件: Aldosterone-regulated sodium reabsorption 💬3件: 6, 17, 81 💬
12 Flutamide 💬1件: Flutamide1件: Flutamide1件: AR 💬 4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 81 💬
13 Hydrocortisone 💬1件: Hydrocortisone3件: Cortisol; Hydrocortisone; Hydrocortisonum1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬8件: 41, 53, 75, 78, 81, 83, 97, 299 💬
14 Letrozole 💬1件: Letrozole1件: Letrozole1件: CYP19A 💬 2件: Ovarian steroidogenesis, Steroid hormone biosynthesis 💬2件: 81, 89 💬
15 Metformin 💬1件: Metformin3件: Metformin; Metformin hydrochloride; Metformina2件: PRKAA,
PRKAA 💬 		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬27件: 2, 6, 8, 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 225, 265, 285, 298, 299, 301 💬
16 Metformin hydrochloride 💬1件: Metformin3件: Metformin; Metformin hydrochloride; Metformina2件: PRKAA,
PRKAA 💬 		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬27件: 2, 6, 8, 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 225, 265, 285, 298, 299, 301 💬
17 Nevanimibe 💬1件: Nevanimibe1件: Nevanimibe hydrochloride--2件: 75, 81 💬
18 Nevanimibe hydrochloride 💬1件: Nevanimibe1件: Nevanimibe hydrochloride--2件: 75, 81 💬
19 Nifedipine 💬1件: Nifedipine1件: Nifedipine4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬 		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 81 💬
20 Pioglitazone 💬1件: Pioglitazone1件: Pioglitazone1件: NR1C3 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬16件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 81, 86, 220, 229, 265, 298, 299 💬
21 Pioglitazone hydrochloride 💬1件: Pioglitazone1件: Pioglitazone1件: NR1C3 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬16件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 81, 86, 220, 229, 265, 298, 299 💬
22 Prednisolone 💬1件: Prednisolone3件: Prednisolona; Prednisolone; Prednisolonum1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬39件: 3, 11, 13, 14, 18, 25, 26, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 60, 63, 64, 66, 81, 84, 85, 96, 97, 113, 145, 162, 222, 251, 269, 271, 296, 299, 300 💬
23 Prednisone 💬1件: Prednisone2件: Prednisona; Prednisone1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬54件: 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 145, 162, 164, 205, 222, 224, 228, 251, 269, 283, 285, 288, 299, 300, 303, 307, 331 💬
24 Tildacerfont 💬1件: Tildacerfont1件: Tildacerfont1件: CRHR1 💬 5件: Cushing syndrome, Hormone signaling, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 81 💬